PMID- 37229870 OWN - NLM STAT- MEDLINE DCOM- 20230605 LR - 20230605 IS - 1090-2414 (Electronic) IS - 0147-6513 (Linking) VI - 259 DP - 2023 Jul 1 TI - Modeling of ionizing radiation-induced chromosome aberration and tumor prevalence based on two classes of DNA double-strand breaks clustering in chromatin domains. PG - 115038 LID - S0147-6513(23)00542-0 [pii] LID - 10.1016/j.ecoenv.2023.115038 [doi] AB - There has been some controversy over the use of radiobiological models when modeling the dose-response curves of ionizing radiation (IR)-induced chromosome aberration and tumor prevalence, as those curves usually show obvious non-targeted effects (NTEs) at low doses of high linear energy transfer (LET) radiation. The lack of understanding the contribution of NTEs to IR-induced carcinogenesis can lead to distinct deviations of relative biological effectiveness (RBE) estimations of carcinogenic potential, which are widely used in radiation risk assessment and radiation protection. In this work, based on the initial pattern of two classes of IR-induced DNA double-strand breaks (DSBs) clustering in chromatin domains and the subsequent incorrect repair processes, we proposed a novel radiobiological model to describe the dose-response curves of two carcinogenic-related endpoints within the same theoretical framework. The representative experimental data was used to verify the consistency and validity of the present model. The fitting results indicated that, compared with targeted effect (TE) and NTE models, the current model has better fitting ability when dealing with the experimental data of chromosome aberration and tumor prevalence induced by multiple types of IR with different LETs. Notably, the present model without introducing an NTE term was adequate to describe the dose-response curves of IR-induced chromosome aberration and tumor prevalence with NTEs in low-dose regions. Based on the fitting parameters, the LET-dependent RBE values were calculated for three given low doses. Our results showed that the RBE values predicted by the current model gradually decrease with the increase of doses for the endpoints of chromosome aberration and tumor prevalence. In addition, the calculated RBE was also compared with those evaluated from other models. These analyses show that the proposed model can be used as an alternative tool to well describe dose-response curves of multiple carcinogenic-related endpoints and effectively estimate RBE in low-dose regions. CI - Copyright (c) 2023 The Authors. Published by Elsevier Inc. All rights reserved. FAU - Zhao, Lei AU - Zhao L AD - Institute of Environmental Systems Biology, College of Environmental Science and Engineering, Dalian Maritime University, Dalian 116026, Liaoning, China. Electronic address: zhaol@dlmu.edu.cn. FAU - Tang, Aiping AU - Tang A AD - College of Science, Dalian Maritime University, Dalian 116026, Liaoning, China. FAU - Long, Fei AU - Long F AD - Institute of Environmental Systems Biology, College of Environmental Science and Engineering, Dalian Maritime University, Dalian 116026, Liaoning, China. FAU - Mi, Dong AU - Mi D AD - College of Science, Dalian Maritime University, Dalian 116026, Liaoning, China. Electronic address: mid@dlmu.edu.cn. FAU - Sun, Yeqing AU - Sun Y AD - Institute of Environmental Systems Biology, College of Environmental Science and Engineering, Dalian Maritime University, Dalian 116026, Liaoning, China. Electronic address: yqsun@dlmu.edu.cn. LA - eng PT - Journal Article DEP - 20230523 PL - Netherlands TA - Ecotoxicol Environ Saf JT - Ecotoxicology and environmental safety JID - 7805381 RN - 0 (Chromatin) RN - 9007-49-2 (DNA) SB - IM MH - Humans MH - *DNA Breaks, Double-Stranded MH - Chromatin MH - Prevalence MH - Linear Energy Transfer MH - Radiation, Ionizing MH - Chromosome Aberrations MH - *Neoplasms MH - DNA/radiation effects MH - Cluster Analysis MH - Dose-Response Relationship, Radiation OTO - NOTNLM OT - Chromosome aberration OT - Ionizing radiation OT - Non-targeted effect OT - Radiobiological model OT - Relative biological effectiveness OT - Tumor prevalence COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/05/26 01:05 MHDA- 2023/06/05 06:42 CRDT- 2023/05/25 18:02 PHST- 2023/02/22 00:00 [received] PHST- 2023/04/24 00:00 [revised] PHST- 2023/05/17 00:00 [accepted] PHST- 2023/06/05 06:42 [medline] PHST- 2023/05/26 01:05 [pubmed] PHST- 2023/05/25 18:02 [entrez] AID - S0147-6513(23)00542-0 [pii] AID - 10.1016/j.ecoenv.2023.115038 [doi] PST - ppublish SO - Ecotoxicol Environ Saf. 2023 Jul 1;259:115038. doi: 10.1016/j.ecoenv.2023.115038. Epub 2023 May 23.